Temperatures, diagnostics and treatment in pediatric cancer patients with fever in neutropenia, NCT01683370

[1]  Guodong Wang,et al.  A retrospective two-center cohort study on the use of routine chest X-ray after peripherally inserted central catheter placement under ultrasound and intracavitary electrocardiography guidance , 2022, Annals of translational medicine.

[2]  Huilong Duan,et al.  PIC, a paediatric-specific intensive care database , 2020, Scientific Data.

[3]  R. Ammann,et al.  Temperatures and blood counts in pediatric patients treated with chemotherapy for cancer, NCT01683370 , 2019, Scientific Data.

[4]  R. Ammann,et al.  Temperatures and blood counts in pediatric patients treated with chemotherapy for cancer, NCT01683370 , 2019, Scientific Data.

[5]  R. Ammann,et al.  Episodes of fever in neutropenia in pediatric patients with cancer in Bern, Switzerland, 1993–2012 , 2019, Scientific Data.

[6]  R. Ammann,et al.  Project 19.2: Pediatric FN Definition 2012 Bern (NCT01683370): 45 prospectively observed episodes of fever in chemotherapy-induced neutropenia in pediatric patients with cancer , 2018 .

[7]  R. Ammann,et al.  Pediatric patients at risk for fever in chemotherapy-induced neutropenia in Bern, Switzerland, 1993-2012 , 2018, Scientific Data.

[8]  R. Ammann,et al.  The influence of different fever definitions on diagnostics and treatment after diagnosis of fever in chemotherapy-induced neutropenia in children with cancer , 2018, PloS one.

[9]  S. Alexander,et al.  Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  A. Martinot,et al.  Risk‐stratification management of febrile neutropenia in pediatric hematology‐oncology patients: Results of a French nationwide survey , 2016, Pediatric blood & cancer.

[11]  K. Thursky,et al.  Core outcomes and definitions for pediatric fever and neutropenia research: A consensus statement from an international panel , 2015, Pediatric blood & cancer.

[12]  R. Ammann,et al.  The Influence of Different Fever Definitions on the Rate of Fever in Neutropenia Diagnosed in Children with Cancer , 2015, PloS one.

[13]  F. Niggli,et al.  Different fever definitions and the rate of fever and neutropenia diagnosed in children with cancer: A retrospective two‐center cohort study , 2013, Pediatric blood & cancer.

[14]  F. Gibson,et al.  Developing a national ‘low risk’ febrile neutropenia framework for use in children and young people's cancer care , 2013, Supportive Care in Cancer.

[15]  F. Gibson,et al.  Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  B. Laurent,et al.  The specific disease burden of neuropathic pain: Results of a French nationwide survey , 2011, PAIN.

[17]  K. Sepkowitz,et al.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  J. Beyene,et al.  Cost-effectiveness of Outpatient Management for Febrile Neutropenia in Children With Cancer , 2011, Pediatrics.

[19]  A. Simon,et al.  Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  A. Hirt,et al.  Risk prediction of fever in neutropenia in children with cancer: A step towards individually tailored supportive therapy? , 2008, Pediatric blood & cancer.

[21]  B. Phillips,et al.  Variation in policies for the management of febrile neutropenia in United Kingdom Children’s Cancer Study Group centres , 2006, Archives of Disease in Childhood.

[22]  W. Ruch,et al.  Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Writing Committee for the International Collaboration on Antimicrobial Treatment of Febrile Neutropenia in Children. , 1997, The Pediatric infectious disease journal.